KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Convertible Debt (2018 - 2025)

Historic Convertible Debt for LifeMD (LFMD) over the last 5 years, with Q2 2025 value amounting to $3.5 million.

  • LifeMD's Convertible Debt fell 7018.03% to $3.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.5 million, marking a year-over-year decrease of 7018.03%. This contributed to the annual value of $9.9 million for FY2024, which is 4486.16% down from last year.
  • According to the latest figures from Q2 2025, LifeMD's Convertible Debt is $3.5 million, which was down 7018.03% from $6.8 million recorded in Q1 2025.
  • LifeMD's Convertible Debt's 5-year high stood at $18.8 million during Q3 2023, with a 5-year trough of $3.5 million in Q2 2025.
  • Moreover, its 3-year median value for Convertible Debt was $13.2 million (2023), whereas its average is $12.3 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first surged by 481.79% in 2024, then crashed by 7018.03% in 2025.
  • LifeMD's Convertible Debt (Quarter) stood at $17.9 million in 2023, then tumbled by 44.86% to $9.9 million in 2024, then tumbled by 64.42% to $3.5 million in 2025.
  • Its Convertible Debt stands at $3.5 million for Q2 2025, versus $6.8 million for Q1 2025 and $9.9 million for Q4 2024.